+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 1 Actively Recruiting clinical trials

R

Actively Recruiting

This study focuses on adults in the United States with schizophrenia who are prescribed xanomeline and trospium chloride XT therapy. It aims to understand patients treatment preferences and satisfaction with this medication combination. The research is observational and tracks real-world experiences rather than testing new treatments. Participants receive xanomeline and trospium chloride therapy according to the product label. The study observes how patients use this treatment and collects information about dosing and any changes over time. Data is gathered at multiple points, including baseline, Month 1, Month 3, and Month 6, to monitor treatment plans and medication adjustments. During the study, participants provide information through questionnaires about their medication preferences and satisfaction. Researchers also collect clinical and demographic data, track treatment plans, dose changes, and reasons for discontinuing therapy. This information helps assess the real-world use and patient experience with XT therapy over approximately six months.

Age: 18Years +All Genders
20 locations